Navigation Links
Healthcare Sector Announced Clinical Data Presentation, Upcoming Financial Release Schedules and Updates on New Drug Applications - Research Report on Alexion, Pacira, pSivida, Momenta and Impax
Date:10/23/2013

atients with aHUS. The Full Research Report on Alexion Pharmaceuticals, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/4619_ALXN]

--

Pacira Pharmaceuticals Inc. Research Report

On October 17, 2013, Pacira Pharmaceuticals Inc. (Pacira) announced that it will release its Q3 2013  financial results before the market opens on October 31, 2013. The Company stated that its management team will host a conference call to discuss its financial results along with recent and upcoming developments on the same day at 9:00 a.m. ET. The Company informed that a live, listen-only webcast of the call will be available at the "Investors & Media" section of the Company's website. Pacira added that the replay of the call for two weeks, approximately two hours following the call will also be accessible at the same location. The Full Research Report on Pacira Pharmaceuticals Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/c0aa_PCRX]

--

pSivida Corp. Research Report

On October 18, 2013, pSivida Corp. (pSivida) announced that its licensee Alimera Sciences, Inc. has received a Complete Response Letter (CRL) for the New Drug Application (NDA) for ILUVIEN from the U.S. Food and Drug Administration (FDA). pSivida informed that the FDA stated that its NDA could not be approved in its present form, due to concerns regarding the benefit to risk and safety profiles of ILUVIEN. The Company informed that in order to address the clinical and statistical deficiencies identified, FDA indicated that results from a new clinical trial would need to be s
'/>"/>

SOURCE Analysts' Corner
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. ViiV Healthcare announces US regulatory submission for a single-tablet regimen combining dolutegravir with abacavir and lamivudine for people living with HIV
2. Global Healthcare Leader Deploys QUOSAs Literature Management Tools
3. Sysmex America Leads Educational Offerings Focused on Healthcare Reforms Impact on the Clinical Laboratory
4. Hyland Software Partners with the Global Center for Healthcare Innovation in Cleveland
5. Allied Healthcare Products Reports Loss On Sales Decline
6. 50 Years Old and Still Bounding Over the Counter: Klines Healthcare Practice Continues to Deliver Unmatched OTC Market Intelligence
7. Experian Healthcare launches tool to enable providers to identify and help enroll eligible individuals for health insurance exchange (HIX) subsidized programs
8. BioSpecifics Technologies Corp. to Present at the Aegis Capital 2013 Healthcare Conference
9. Orange County Hospital System, Integrated Healthcare Holdings, Joins ApolloMed ACO
10. ViiV Healthcare Presents Positive Data from Phase IIIb/IV Study of Dolutegravir vs Darunavir in Treatment-Naive Adults with HIV-1
11. Hubble Telemedical Welcomes Healthcare Visionary Jonathan Lord, M.D. to Its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... 30, 2014 Electronic prescribing or ... of prescription related information between prescriber, dispenser ... a physician and nurse practitioner to transmit ... error occurs during pharmacy operations. E-Prescribing system ... provides complete medical lists, conducts all security ...
(Date:10/31/2014)... Oct. 31, 2014  AbbVie (NYSE: ... third quarter ended Sept. 30, 2014. ... of our business with double-digit growth from HUMIRA ... grew nearly 14 percent in the quarter excluding ... executive officer, AbbVie.  "We exceeded our outlook for ...
(Date:10/30/2014)... MAHWAH, N.J. , Oct. 30, 2014 ... PGA TOUR and Champions Tour, is rounding out its ... Cup Championship in Scottsdale, AZ. ... PGA TOUR and Champions Tour that the brand has ... destination designed to educate golf fans on the importance ...
Breaking Medicine Technology:E-Prescribing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 2AbbVie Reports Third-Quarter 2014 Financial Results 2AbbVie Reports Third-Quarter 2014 Financial Results 3AbbVie Reports Third-Quarter 2014 Financial Results 4AbbVie Reports Third-Quarter 2014 Financial Results 5AbbVie Reports Third-Quarter 2014 Financial Results 6AbbVie Reports Third-Quarter 2014 Financial Results 7AbbVie Reports Third-Quarter 2014 Financial Results 8AbbVie Reports Third-Quarter 2014 Financial Results 9AbbVie Reports Third-Quarter 2014 Financial Results 10AbbVie Reports Third-Quarter 2014 Financial Results 11AbbVie Reports Third-Quarter 2014 Financial Results 12AbbVie Reports Third-Quarter 2014 Financial Results 13AbbVie Reports Third-Quarter 2014 Financial Results 14AbbVie Reports Third-Quarter 2014 Financial Results 15AbbVie Reports Third-Quarter 2014 Financial Results 16AbbVie Reports Third-Quarter 2014 Financial Results 17AbbVie Reports Third-Quarter 2014 Financial Results 18AbbVie Reports Third-Quarter 2014 Financial Results 19AbbVie Reports Third-Quarter 2014 Financial Results 20AbbVie Reports Third-Quarter 2014 Financial Results 21AbbVie Reports Third-Quarter 2014 Financial Results 22AbbVie Reports Third-Quarter 2014 Financial Results 23AbbVie Reports Third-Quarter 2014 Financial Results 24Stryker Mobility Zone Makes Final Stop Of 2014 At Charles Schwab Cup Championship 2Stryker Mobility Zone Makes Final Stop Of 2014 At Charles Schwab Cup Championship 3Stryker Mobility Zone Makes Final Stop Of 2014 At Charles Schwab Cup Championship 4
... Show Increased Enzyme Levels in Two Most ... /PRNewswire/ -- Amicus,Therapeutics, a biopharmaceutical company developing ... a range of human genetic diseases, announced ... preclinical studies of,Plicera(TM) (isofagomine tartrate, AT2101) for ...
... the Targeted,Anticancer Therapies (TAT 2007) and the ... Phase 1 Trial Design, SOUTH SAN FRANCISCO, ... Inc. , presented,non-clinical data on its development-stage ... on targeted anticancer,medicines. Findings from in vitro ...
Cached Medicine Technology:Amicus Therapeutics Presents Preclinical Data from Studies of,Plicera for Gaucher Disease 2Amicus Therapeutics Presents Preclinical Data from Studies of,Plicera for Gaucher Disease 3Sunesis Pharmaceuticals Presents SNS-314 Aurora Kinase Inhibitor,Data Showing Broad Anti-Tumor Activity, Dosing Flexibility 2Sunesis Pharmaceuticals Presents SNS-314 Aurora Kinase Inhibitor,Data Showing Broad Anti-Tumor Activity, Dosing Flexibility 3
(Date:10/31/2014)... 2014 — A team from the Broad Institute, ... of California, Santa Cruz, was awarded one of ... Pilot contracts with the goal of building a ... Cancer Genome Atlas (TCGA) and other datasets by ... in one cloud environment. This co-location will enable ...
(Date:10/31/2014)... At the start of 2014, numerous news ... monoxide poisoning in their homes. Now, as 2015 (and ... Missouri-based heating and cooling company is taking a more ... the home heating season with the assurance that their ... Nov. 1, 2014, E and Q Heating and Cooling ...
(Date:10/31/2014)... apnea may make it hard for you to remember simple ... your house keys, a small study suggests. Tests on ... -- called spatial memory -- was impaired when sleep apnea ... of sleep weren,t affected. REM sleep is the deepest level ... for the first time that sleep apnea, an increasingly common ...
(Date:10/31/2014)... lab device to give cancer researchers an unprecedented microscopic ... spread through the body, causing more than 90 percent ... tumor cells travel, the device could uncover new ways ... the university,s Whiting School of Engineering and its Institute ... new system recently in the journal Cancer Research ...
(Date:10/31/2014)... scientists have found a drug combination that can trigger ... the way for new treatments, according to research that ... (NCRI) Cancer Conference in Liverpool next week*. , When ... chain of events culminating in self destruction. But cancer ... immortal. This means that cells grow out of control ...
Breaking Medicine News(10 mins):Health News:Broad Institute, Univ. of California team awarded NCI Cancer Genomics Cloud Pilot contract 2Health News:Broad Institute, Univ. of California team awarded NCI Cancer Genomics Cloud Pilot contract 3Health News:Many Homeowners Missing Key Safety Risks with Home Heating;Missouri-based Company E and Q Announces New Safety Check 2Health News:Many Homeowners Missing Key Safety Risks with Home Heating;Missouri-based Company E and Q Announces New Safety Check 3Health News:Sleep Apnea May Steal Some of Your Memory: Study 2Health News:Viewing cancer on the move: New device yields close-up look at metastasis 2Health News:Viewing cancer on the move: New device yields close-up look at metastasis 3Health News:Scientists trigger self-destruct switch in lung cancer cells 2
... America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood ... ) focused on bringing the life saving potential of ... announce that between February 15, 2009, and today, it has ... percent. This follows the announcement on Feb. 12, 2009 ...
... Stars Perform to Raise Awareness of Neurological DiseaseEAST RUTHERFORD, N.J., April ... Foundation: WHO: Anthony Galde of Wicke ... Research Foundation WHAT: Curtain Call for a Caus ... & the Dystonia Medical Research Foundation host the 2nd Annual ...
... The United States Marine Corps launches its inaugural ... city opens its doors to the nearly 2,000 Marines ... Chicagoland area. "Established to recognize the contributions of ... which they came, Marine Week also showcases the rich ...
... arthritis (RA) is a systemic disease or an autoimmune disorder ... the thin layer of cells called the synovium that lines ... are swollen joints and crippling stiffness, particularly of the hands ... and also impedes mobility and quality of life. RA cannot ...
... vaccines and critical-care biopharmaceuticals announces exclusive sanofi pasteur Fluzone® agreement for ... ... (Vocus) April 6, 2009 -- As a trusted partner ... is pleased to announce that sanofi pasteur has named FFF the ...
... Lens Boot Camp™ - a first-of-its-kind training program to help refractive ... that its first boot camp session will be held on June ... ... Camarillo, CA (PRWEB) April 6, 2009 -- Premium Lens Boot Camp™ ...
Cached Medicine News:Health News:Cord Blood Announces $1.75 Million Reduction in Long Term Debt 2Health News:Broadway Comes to New Jersey 2Health News:Marine Corps Launches Inaugural Marine Week in Chicago, May 11-17 2Health News:Marine Corps Launches Inaugural Marine Week in Chicago, May 11-17 3Health News:Rheumatoid Arthritis Therapeutics in Thailand 2Health News:Rheumatoid Arthritis Therapeutics in Thailand 3Health News:FFF Named the Exclusive Distributor of Fluzone for GPOs & Announces New Fluzone Return Policy 2Health News:Premium Lens Boot Camp™ Helps Refractive Surgeons Grow Their Premium IOL Practice 2
Cordis DUCOR Catheters are available in a broad variety of French sizes and configurations. These catheters combine an atraumatic tip with either a braided or non-braided body....
The advanced center-of-the-arc system allows an infinite choice of trajectories. The system's lightweight durable frame provides accuracy, simplicity, patient mobility and accessibility....
The CRW system epitomizes simplicity, quality assurance, and versatility....
Used for complex diagnostic and interventional procedures....
Medicine Products: